NextCure, Inc.
NXTC
$8.21
-$0.07-0.85%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -14.89M | -9.80M | -9.44M | -8.62M | -26.81M |
| Total Depreciation and Amortization | 272.00K | 283.00K | 365.00K | 533.00K | 633.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.50M | 439.00K | 537.00K | 702.00K | 585.00K |
| Change in Net Operating Assets | -596.00K | -4.29M | 896.00K | 1.12M | 2.88M |
| Cash from Operations | -9.72M | -13.36M | -7.64M | -6.27M | -22.71M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 9.79M | 1.30M | 6.00M | 8.70M | 3.76M |
| Cash from Investing | 9.79M | 1.30M | 6.00M | 8.70M | 3.76M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 22.00K | 1.25M | 21.52M | 0.00 | 2.02M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -1.22M | -- | -- |
| Cash from Financing | 22.00K | 1.25M | 20.29M | 0.00 | 2.02M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 93.00K | -10.82M | 18.66M | 2.43M | -16.94M |